WITHDRAWN: Clearance of Lysosomal Glycogen Accumulation by Transcription Factor EB (TFEB) in Muscle Cells from Lysosomal Alpha-glucosidase Deficient Mice

Overview

Journal Biochem Biophys Res Commun

Publisher Elsevier

Specialty Biochemistry

Date 2013 Feb 19

PMID 23416076

Citations 1

Authors

Hoi Ming Li

Erin Feeney

Lishu Li

Hossein Zare

Rosa Puertollano

Nina Raben

Affiliations

Soon will be listed here.

Abstract

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

Citing Articles

The Release of a Soluble Glycosylated Protein from Glycogen by Recombinant Lysosomal α-Glucosidase (rhGAA) In Vitro and Its Presence in Serum In Vivo.

Murray A Biomolecules. 2020; 10(12).

PMID: 33260301 PMC: 7761001. DOI: 10.3390/biom10121613.

References

Mouly V, Edom F, Decary S, Vicart P, Barbert J, Butler-Browne G . SV40 large T antigen interferes with adult myosin heavy chain expression, but not with differentiation of human satellite cells. Exp Cell Res. 1996; 225(2):268-76. DOI: 10.1006/excr.1996.0176. View

Liu Q, Chang J, Wang J, Kang S, Thoreen C, Markhard A . Discovery of 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a highly potent, selective mammalian target of rapamycin (mTOR) inhibitor for the treatment of cancer. J Med Chem. 2010; 53(19):7146-55. PMC: 3893826. DOI: 10.1021/jm101144f. View

Kroos M, Hoogeveen-Westerveld M, van der Ploeg A, Reuser A . The genotype-phenotype correlation in Pompe disease. Am J Med Genet C Semin Med Genet. 2012; 160C(1):59-68. DOI: 10.1002/ajmg.c.31318. View

Raben N, Schreiner C, Baum R, Takikita S, Xu S, Xie T . Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder--murine Pompe disease. Autophagy. 2010; 6(8):1078-89. PMC: 3039718. DOI: 10.4161/auto.6.8.13378. View

Cox T, Cachon-Gonzalez M . The cellular pathology of lysosomal diseases. J Pathol. 2011; 226(2):241-54. DOI: 10.1002/path.3021. View

Rosenblatt J, Lunt A, Parry D, Partridge T . Culturing satellite cells from living single muscle fiber explants. In Vitro Cell Dev Biol Anim. 1995; 31(10):773-9. DOI: 10.1007/BF02634119. View

van den Hout J, Kamphoven J, Winkel L, Arts W, de Klerk J, Loonen M . Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. Pediatrics. 2004; 113(5):e448-57. DOI: 10.1542/peds.113.5.e448. View

Settembre C, Di Malta C, Polito V, Garcia Arencibia M, Vetrini F, Erdin S . TFEB links autophagy to lysosomal biogenesis. Science. 2011; 332(6036):1429-33. PMC: 3638014. DOI: 10.1126/science.1204592. View

Raben N, Shea L, Hill V, Plotz P . Monitoring autophagy in lysosomal storage disorders. Methods Enzymol. 2009; 453:417-49. PMC: 2669416. DOI: 10.1016/S0076-6879(08)04021-4. View

10.

Koeberl D, Li S, Dai J, Thurberg B, Bali D, Kishnani P . β2 Agonists enhance the efficacy of simultaneous enzyme replacement therapy in murine Pompe disease. Mol Genet Metab. 2011; 105(2):221-7. PMC: 3264842. DOI: 10.1016/j.ymgme.2011.11.005. View

11.

Sardiello M, Palmieri M, di Ronza A, Medina D, Valenza M, Gennarino V . A gene network regulating lysosomal biogenesis and function. Science. 2009; 325(5939):473-7. DOI: 10.1126/science.1174447. View

12.

Roczniak-Ferguson A, Petit C, Froehlich F, Qian S, Ky J, Angarola B . The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci Signal. 2012; 5(228):ra42. PMC: 3437338. DOI: 10.1126/scisignal.2002790. View

13.

Huang H, Chen P, Hwu W, Chuang C, Chien Y, Stone L . Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification. Hum Mol Genet. 2011; 20(24):4851-64. DOI: 10.1093/hmg/ddr424. View

14.

Lieberman A, Puertollano R, Raben N, Slaugenhaupt S, Walkley S, Ballabio A . Autophagy in lysosomal storage disorders. Autophagy. 2012; 8(5):719-30. PMC: 3378416. DOI: 10.4161/auto.19469. View

15.

Cao Y, Espinola J, Fossale E, Massey A, Cuervo A, MacDonald M . Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis. J Biol Chem. 2006; 281(29):20483-93. DOI: 10.1074/jbc.M602180200. View

16.

Liao G, Yao Y, Liu J, Yu Z, Cheung S, Xie A . Cholesterol accumulation is associated with lysosomal dysfunction and autophagic stress in Npc1 -/- mouse brain. Am J Pathol. 2007; 171(3):962-75. PMC: 1959498. DOI: 10.2353/ajpath.2007.070052. View

17.

Settembre C, Zoncu R, Medina D, Vetrini F, Erdin S, Erdin S . A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 2012; 31(5):1095-108. PMC: 3298007. DOI: 10.1038/emboj.2012.32. View

18.

Medina D, Fraldi A, Bouche V, Annunziata F, Mansueto G, Spampanato C . Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev Cell. 2011; 21(3):421-30. PMC: 3173716. DOI: 10.1016/j.devcel.2011.07.016. View

19.

Funk B, Kessler U, Eisenmenger W, Hansmann A, Kolb H, Kiess W . Expression of the insulin-like growth factor-II/mannose-6-phosphate receptor in multiple human tissues during fetal life and early infancy. J Clin Endocrinol Metab. 1992; 75(2):424-31. DOI: 10.1210/jcem.75.2.1379254. View

20.

Takikita S, Myerowitz R, Zaal K, Raben N, Plotz P . Murine muscle cell models for Pompe disease and their use in studying therapeutic approaches. Mol Genet Metab. 2009; 96(4):208-17. PMC: 2680079. DOI: 10.1016/j.ymgme.2008.12.012. View